How Attractive Is Germany To Companies Focussed On Pharmaceutical Research & Development?

BMI Core View: Research and development (R&D) offshoring to low cost bases will accelerate. Multinational drugmakers used to conduct the discovery of medicines either domestically or in countries where their products were generally sold - specifically the US, Western Europe and Japan. However, due to rising costs in developed states, improving education standards in emerging markets and a shift in consumer demand, R&D centres are increasingly offshored.

To read the full article, please choose one of the following options: